TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ELAN

Elanco Animal Health

Healthcare · Drug Manufacturers - Specialty & Generic

22.40$ -1.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Elanco Animal Health (ELAN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,368 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ELAN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
1,068 1,035 1,205 1,184 1,030 1,020 1,193 1,241 1,137 1,144 1,371 1,368 5,020
627 654 648 626 625 631 637 664 530 694 586 570 2,380
441 381 557 558 405 389 556 577 607 450 785 798 2,640
86 79 87 89 87 81 94 92 89 93 97 92 371
313 85 337 354 323 300 341 400 351 338 381 449 1,519
399 371 424 443 410 381 435 492 580 431 478 689 2,178
42 10 133 115 -5.0 8.0 121 85 27 19 307 109 462
72 67 66 65 85 62 53 70 52 91 57 59 259
-1,097 -127 12 -32 559 -51 60 25 -50 -259 87 56 -166
-1.0 14 -20 18 195 -43 -7.0 14 -16 17 30 2.0 33
-1,096 -141 32 -50 364 -8.0 67 11 -34 -276 57 54 -199
-852 111 244 195 814 175 274 264 178 6.0 316 274 774

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?